β¨ Medicines Consent Notices
NEW ZEALAND GAZETTE, No. 92 β 27 AUGUST 2015
2015-go5010
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Active Ingredient: Efmoroctocog alfa 250IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
ELOCTATE
Product:
Active Ingredient: Efmoroctocog alfa 500IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
ELOCTATE
Product:
Active Ingredient: Efmoroctocog alfa 750IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
ELOCTATE
Product:
Active Ingredient: Efmoroctocog alfa 1000IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
ELOCTATE
Product:
Active Ingredient: Efmoroctocog alfa 1500IU
Dosage Form: Powder for infusion
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
ELOCTATE
Product:
Active Ingredient: Efmoroctocog alfa 2000IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
ELOCTATE
Product:
Active Ingredient: Efmoroctocog alfa 3000IU
Dosage Form: Powder with diluent
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
ELOCTATE
Product:
Active Ingredients:
- Glycopyrronium bromide 0.5mg/mL
- Neostigmine metilsulfate 2.5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ)
Manufacturer: B Braun Melsungen AG, Berlin, Germany
Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per mL
Product:
Active Ingredient: Ibuprofen 200mg
Dosage Form: Coated tablet
New Zealand Sponsor: Nova Pharmaceuticals NZ Limited
Manufacturer: Marksans Pharma Limited, Goa, India
MEDIX Ibuprofen
Dated this 24th day of August 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister)
50
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare24 August 2015
Medicines, Consent, Distribution, New Zealand, Medicines Act 1981
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2015, No 92